So -- while Tangerine talked about price reform, he did literally nothing for four years. Mr. Biden may not be so feckless. Here's what Merck lobbied about. Mr. Davis has some very big shoes to fill -- to make headway -- on all these issues:
. . .H.R. 597, Pandemic Treatment Access and Affordability Act of 2021; H.R. 959, Black Maternal Health Omnibus Act of 2021; H.R. 1319, American Rescue Plan Act of 2021, medical provisions; H.R. 1550, PREVENT HPV Cancers Act of 2021; H.R. 2061, To establish an interagency One Health Program, and for other purposes; H.R. 3, (116th Congress) Lower Drug Costs Now Act of 2019; H.R. 19 (116th Congress) Lower Costs, More Cures Act of 2019; H.R. 133 (116th Congress) Consolidated Appropriations Act of 2021 AMP cap provision; H.R. 4100/S. 1712 (116th Congress) Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019; S. 1895 (116th Congress) Lower Health Care Costs Act. . . .
Issues relating to 340B program integrity; 340B of the Public Health Services Act; 340B policy; 340B issues; 340 drug pricing program; Drug pricing; Drug Pricing reforms - international reference prices and government price setting; Anti-microbial Resistance; Maternal Health; Cost and value of medicines; Vaccines; HIV, PrEP provisions; COVID-19 vaccines; COVID-19 vaccine funding; COVID-19 therapeutics coverage issues; Vaccines catch up; Vaccine provisions; Vaccine Issues, including access and pandemic-related policy; General pharmaceutical issues; Package inserts and labeling issues; Average Manufacture Price (AMP) cap; Executive Order 13937, Access to Affordable Life-Saving Medications; FY-2022 Budget and Appropriations Legislation; Intellectual property; WTO Trade-Related Aspects of Intellectual Property Rights (TRIPS) Agreement; Animal Health; One Health Issues; Rural Broadband Issues. . . .
H.R. 1319, American Rescue Plan Act of 2021, Medicaid provisions and AMP Cap; H.R. 3, (116th Congress) Lower Drug Costs Now Act of 2019, provisions related to Medicare Part B, S. 476 (116th Congress) Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2019, S. 2543 (116th Congress) Prescription Drug Pricing Reduction Act of 2019, including provisions relating to AMP cap and Medicare Part D rebate. . . .
Issues relating to AMP-Cap; Medicaid; Medicare Part B; Medicare Part B and D drug pricing issues; Medicare Part D, Six Protected Classes; 340B program integrity; 340B of the Public Health Services Act; 340B drug pricing program; Medicare Part D; Drug Pricing; Center for Medicare and Medicaid demonstrations; FY-2022 Budget and Appropriations Legislation. . . .
Issues related to Tax reform and tax policy, generally; Tax Cuts and Jobs Act of 2017 (P.L. 115-97). . . .
Obviously this is a much wider, and deeper, portfolio than the company had pursued at any time since mid-2016. And that too makes sense. Onward, grinning -- to a five year old's backyard birthday party, next. . . .
नमस्ते
No comments:
Post a Comment